Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Alexion raises guidance as French HTA says yes to Soliris

12.03.2014 / Scripintelligence

Alexion Pharmaceuticals has revised its previously stated 2014 guidance following successful discussions with the French reimbursement authority concerning its orphan drug Soliris (eculizumab).

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: